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A stratified version of nested case-control sampling which we call "countermatching" is presented. This design uses data available for all cohort
members to obtain a sample for collecting additional information in a case-control substudy. Hitherto the only stratified sampling design for such
studies has involved matching of controls to cases with respect to confounding variables. However, in some situations, rather than sampling to
make controls as similar as possible to cases, we might wish to make them as different as possible. This is achieved by the counter-matched
design. Statistical analysis of counter-matched studies is straightforward using existing computer software. We investigate the use of the design
when a surrogate measure of exposure is available for the full cohort, but accurate exposure data is to be collected only in a nested case-control
study, and when exposure data are available for the whole cohort but data concerning important confounders are not. Asymptotic relative efficiency
calculations indicate that a substantial efficiency gain relative to simple random sampling of controls can be expected in these situations. We also
illustrate how the design might be implemented in practice. - Environ Health Perspect 102(Suppl 8):47-51 (1994)
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Introduction
Epidemiologic cohort studies are considered
the most reliable design for studying risk
factors for disease incidence for two reasons.
First, prospective collection of biologic
marker, demographic, and environmental
data avoids the information bias that may
occur in retrospective data collection.
Second, case-control studies are prone to
selection bias attributable to flawed sam-
pling ofbase populations.
Ideally, complete and accurate risk factor
data would be acquired for every subject in
the cohort. However, since incidences of
diseases such as cancer are rare events,
study cohorts usually must be very large
and fewer resources usually can be devoted
to collecting risk factor data for any one
subject than would be possible in a retro-
spective case-control study. Thus the
choice between the two study methods is
often a choice between higher reliability
with sparse data and lower reliability with
more complete data.
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A cost effective compromise is to iden-
tify all risk factors that would be subject to
possible bias in retrospective data collection
and, at the time ofrecruitment ofa subject
into a cohort study, to collect the source
materials necessary to generate such data in
a nested case-control study. When the pro-
cessing of such source materials is costly
relative to their collection, this design
achieves the economy of the case-control
method while avoiding the problems of
selection bias and retrospective data collec-
tion which compromise the retrospective
case-control method.
There are many instances in which the
processing ofsource materials for risk factor
measurements is costly. These include, for
example, coding ofrecords ofdiet, exercise
or occupational exposure, and laboratory
analysis ofblood and urine samples. In all
these cases, the source materials, whether
paper records or biologic samples, can be
banked when the subject is recruited but
analyzed in detail only for a relatively small
number ofcases and controls.
Another situation in which nested case-
control studies can be valuable is when a
study cohort can be identified opportunis-
tically from records collected for another
purpose and mechanisms exist for registering
disease events ofinterest, butwhere riskfactor
data for individual subjects are scant. These
data maybe augmented in cases and asample
of controls drawn from the study cohort.
Although the problem of information bias
due to retrospective data collection remains,
selection bias is avoided in such studies.
This article discusses the design of
nested case-control studies with particular
emphasis on new possibilities arising out of
recent advances in analytical methods.
Sampling Risk Sets
Although the use of nested case-control
studies goes back at least to the 1960s (1)
and the idea was more formally proposed
by Mantel (2), their analysis and logical
basis have been considerably clarified by
the idea of partial likelihood. This was
introduced by Cox (3) and further devel-
oped by a number ofothers throughout the
1970s, culminating in the work of
Anderson and Gill (4). The main idea is
illustrated in Figure 1, which represents a
small study of 11 subjects. Each horizontal
line represents the observation of a single
subject through time. Termination of the
observation line by a vertical bar represents
end ofstudy without occurrence ofthe dis-
ease ofinterest (censoring) and termination
by a filled circle represents disease inci-
Figure 1. Definition of risk sets.
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dence. Thus, in the study shown, four cases
ofdisease were observed. Corresponding to
each case is a risk set, consisting ofall sub-
jects under study at the moment ofevent
occurrence-in the diagram all subjects
whose observation lines cross the relevant
vertical. The partial likelihood method
compares risk factor profiles ofcases with
the profiles in the corresponding risk sets.
If, for each subject, we express the
probability rate of disease incidence as a
multiple, 0, ofa "baseline" time trajectory,
each disease event contributes a term ofthe
form
log(0(fo,case)/risAete)
to the log partial likelihood. Standard max-
imum likelihood methods may then be
used to fit models for 0 as a function of
risk factors.
A nested case-control study is generated
by sampling the risk set-the risk set is
replaced by a set containing the case and a
random sample of all the remaining sub-
jects in the set (the case-control set). The
statistical analysis is otherwise unchanged,
the log partial likelihood contribution for
each event being
l1g(9(f.rcase)/case-control set 6)
which is identical to that for "conditional"
logistic regression analysis of individually
matched case-control studies.
The loss ofpower for testing associa-
tion when this stategy is adopted is surpris-
ingly small. Ifm-1 controls are selected for
each case, the relative efficiency, the ratio
of the (large sample) variance of the esti-
mated coefficient from the nested case-con-
trol study to that using the full cohort, is
(rm-1)I/m (5,6). This relative efficiency
refers to the test ofassociation between dis-
ease and a single explanatory factor; after
adjustment for confounding, the efficiency
ofthe nested case-control study may not be
so good.
The above discussion assumes that no
information is available about the subjects
in the study cohort except for their obser-
vation periods and their disease status.
Almost always, however, some incomplete
risk factor data will be available for every
subject. There is now the possibility of
stratified sampling ofcontrols-we classify
members ofeach risk set into strata accord-
ing to this incomplete data, and sample the
different strata independently. We shall
consider two such stratified sampling
schemes.
Mathing
In matched nested case-control studies,
controls are drawn from the same stratum
as the case; the number ofcontrols drawn
from each stratum may be chosen to vary
according to where the case falls. The par-
tial likelihood is unchanged and compar-
isons between cases and controls are made
within strata. Thus, stratifying variables are
treated as confounders. This design is well
known and its aim is efficient control for
confounding. Its limitation is that effects
ofstratifying variables, after controlling for
any variables in the sample, cannot be esti-
mated, although their role as effect
modifiers may be studied. Matching for
variables that are not to be regarded as con-
founders is to be avoided, first because its
effect cannot be estimated and second
because the study loses power with respect
to variables associated with it (the problem
ofovermatching).
Counter-matching
An alternative stratified design with quite
different aims has recently been proposed
(7). This design employs stratified sam-
pling of controls with strata determined
not by confounders but by variables of
interest in the analysis, or by proxies for
such variables. The aim of the design is,
again, improvement in efficiency; but to
achieve efficiency in this case, we require a
design that is almost directly opposite to
matching. Whereas the aim ofstratified
sampling by confounders is to yield con-
trols that are as similar as possible to the
cases, stratified sampling by exposures of
interest aims to maximize the variation of
exposure within case-control sets.
We will denote the total number of
subjects in a risk set by n, and the numbers
falling into exposure categories 0, 1,... by
no, nl,... respectively. We require a differ-
ent distribution ofsubjects in our nested
case-control study-mo, mI,... let us say.
This requires that, ifstratum icontains the
case, we draw at random a sample ofsize
mi-1 from the n,-I eligible subjects and,
ifstratum i does not contain the case, we
draw mi from ni. The name "counter-
matching" for the above design is suggested
by the special case of the 1:1 study when
there are two sampling strata and we
require mo= ml = 1. In this case the design
requires that the control be drawn from the
opposite stratum to the case.
The partial likelihood method ofanaly-
sis may be simply adapted to the counter-
matched design. The contribution ofeach
case-control set to the log partial likelihood
becomes
log[(WO)(fo,case)/case-controlset(We)
where Ware riskweights that depend upon
the sampling stratum from which the sub-
ject is drawn. For a subject drawn from
sampling stratum i, the riskweight is
W = ni.
mi
Note that risk weights apply not only to
controls but also to cases.
This method of analysis allows us
simultaneously to estimate effects of the
stratifying variables, which are measured in
the whole cohort, and offurther variables
available only in the nested case-control
study. Computer implementation of the
analysis is straightforward, using existing
programs for conditional logistic regression
or for Cox's life table regression. Some
packages explicitly allow the definition of
prior risk weights while in others the same
effect can be achieved by use ofan offset in
alog-linear regression model.
When to Use
Counter-matching
The need for matching has been exten-
sively debated in the epidemiologic litera-
ture and is now well understood. If there
are strong confounders whose effects must
be controlled in the analysis, failure to
match for them in the case-control study
means that the efficiency ofthe study rela-
tive to a full cohort study may fall well
short ofthe (m-1)/m rule indicated above.
This relative efficiency can be recovered,
however, by drawing matched controls
from the same confounder stratum as the
case.
The counter-matched design, however,
is novel. In this section we shall indicate
some possible uses of the design and pre-
sent some illustrative calculations ofits rel-
ative efficiency using formulas derived in
Langholz and Borgan (7).
Counter-mathingby
SurrogateExposure
It may be that a crude measure ofexposure
is easily obtained for all subjects in a cohort
study, but good exposure measurements
are expensive to collect. In these circum-
stances it can be advantageous to stratify
risk sets according to the surrogate expo-
sure measure and to sample controls
according to the counter-matched design.
Example 1. Breast Cancer and Oral
Contraceptives (OCs). In pharmicoepi-
demiologic studies, subjects can accurately
remember if and when medication was
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used but are much less likely to remember
the exact name of the drug. The control
selection would then be stratified by
whether the subject took any ofthe drugs
within the class. For instance, suppose it is
ofinterest to assess the risk ofbreast cancer
from a specific formulation oforal contra-
ceptive as part of a larger cohort study of
breast cancer. Women could be asked, on a
mailed questionnaire, the dates that they
took oral contraceptives. This information
is likely to be quite accurate (granting that
some women may not wish to answer the
question). However, the mailed question-
naire is much less likely to provide accurate
information about the exact brand names
of OCs used since subjects will have a
much poorer memory ofsuch details. Thus
it is natural to consider conducting a
nested case-control study in which medical
records are obtained or subjects are inter-
viewed personally to obtain accurate brand
name information. While a simple nested
case-control sample could be considered, it
would seem wasteful of the preliminary
data held for the full cohort. Counter-
matching makes use ofthis information to
obtain a more informative case-control
study.
Example 2. Pancreatic Cancer and
Occupational Exposure. In occupational
cohort studies, personnel records may con-
tain enough data about workplace history
to provide a surrogate exposure measure.
An example is the actual investigation of
the role of occupational exposures in the
risk of pancreatic cancer in a cohort of
5886 chemical manufacturing workers (8).
Basic information about each employee
was available from the company's person-
nel records, including job titles and work-
place at the plant. There were 28 cases of
pancreatic cancer and, as stratified sam-
pling was not known at the time, a simple
1:4 matched nested case-control study was
drawn and detailed chemical exposure
information was obtained for the 140 sub-
jects in the sample. A counter-matched
design would have been well suited to this
situation. Each ofthe 28 cases and the cor-
responding risk sets would be stratified
according to the estimated level ofgeneral
chemical exposure calculated from job
titles and workplace location histories, and
counter-matched sampling would be car-
ried out as indicated above.
Relative efficiency calculations indicate
that the efficiency advantage of counter-
matching over simple sampling in these sit-
uations can be substantial. Let Zrepresent
a dichotomous exposure and Z be a crude
measure of it, also dichotomous, and
denote the rate ratio for exposure by yV:
Incidence rate (Z = 1)
Incidence rate (Z = 0)
Tables 1 and 2 investigate the asymp-
totic relative efficiency (ARE) of the 1:1
counter-matched design as compared with
a simple 1:1 unstratified design defined by
AR(E = VarianceoflogUfromsimplestudy
Varianceoflog 'rfrom
counter-matchedstudy
in relation to the rate ratio yr, the probabil-
ity ofexposure Pr(Z= 1), the sensitivity of
the surrogate measure Pr(z= 1IZ= 1), and
its specificity Pr(Z=OIZ=0). At the null
hypothesis, ty=l, the ARE ofthe counter-
matched design depends on the sensitivity
and specificity of the surrogate exposure
measure but not on the probability of
exposure. Denoting the false positive and
false negative probabilities by a and f3
respectively, so that the sensitivity is 1-f
and the specificity is 1-a,
ARE,,=J =2[(1-a)(1-f3)+afi.
This relationship is illustrated in Table 1.
Note that the ARE obtained by measuring
true exposure in the full cohort relative to a
simple 1:1 nested study is 2. As we might
expect, this is achieved when the sensitivity
and specificity are both 1 (a=/,=0). Table
2 investigates the efficiency of the design
well away from the null (yr=4). In this case
the ARE of the counter-matched design
depends on the probabilities ofexposure in
the cohort, and three values are investi-
gated in the table (0.05, 0.1, and 0.2). The
counter-matched design has an efficiency
advantage in all the circumstances investi-
gated, this advantage increasing with the
rarity of exposure. Even when the crude
measure is not very predictive of exposure,
the counter-matched design can be sub-
stantially more efficient than a simple sam-
pling design.
Without using counter-matching, the
only way to achieve greater efficiency in a
nested case-control study is to increase the
number of controls drawn for each case.
However, this can be much less cost effec-
tive than counter-matching. Table 1 shows
(in parentheses) the number of controls,
mr-I required in a simple 1:m-1 design to
achieve the same efficiency as the counter-
matched 1:1 design. For example, if the
surrogate measurement has specificity of
1.0 but a sensitivity of 0.8, a simple
unstratified study would require four con-
trols for each case to achieve the same effi-
ciency as a 1:1 counter-matched design. In
this case the counter-matched design
achieves 80% ofthe full cohort efficiency.
Counter-matching byExposure
Suppose that exposure information has
been collected and coded for all cohort
subjects and there is an observed associa-
tion between this exposure and disease.
The next natural step in assessing whether
this association is causal is to see whether it
can be explained by the confounding effect
of other factors, as yet unmeasured. To
answer this question it is natural to collect
detailed data concerning potential con-
founders in a nested case-control study.
Ifthe exposure ofinterest is rare, a sim-
ple nested case-control design might
include few exposed controls and the distri-
bution ofconfounders in this group might
be poorly estimated. A more efficient
Table 1. Asymptotic relative efficiencies for 1:1
counter-matching by a surrogate exposure measure.
Specificity
Sensitivity 1.0 0.9 0.8
0.40 0.80 0.84 0.88
0.50 1.00 (1) 1.00 1.00
0.70 1.40 (2) 1.32 1.24
0.80 1.60 (4) 1.48 1.36
0.90 1.80 (9) 1.64 1.48
0.95 1.90 (19) 1.72 1.54
1.00 2.00 (co) 1.80 1.60
Table 2. ARE for 1:1 counter-matching by surrogate exposure, y=4.
Pr(Z=1)=0.05 Pr(Z=l)=0.1 Pr(Z=1)=0.2
Specificity Specificity Specificity
Sensitivity 1.0 0.9 0.8 1.0 0.9 0.8 1.0 0.9 0.8
0.40 1.89 1.42 1.16 1.79 1.38 1.14 1.61 1.30 1.11
0.50 2.33 1.72 1.36 2.17 1.65 1.33 1.92 1.53 1.28
0.70 3.17 2.31 1.76 2.89 2.17 1.69 2.46 1.94 1.57
0.80 3.57 2.59 1.95 3.23 2.41 1.86 2.70 2.12 1.70
0.90 3.97 2.87 2.14 3.54 2.64 2.02 2.92 2.29 1.82
0.95 4.16 3.00 2.23 3.70 2.76 2.10 3.03 2.37 1.87
1.00 4.35 3.14 2.33 3.85 2.87 2.17 3.12 2.45 1.92
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design would draw more equal-sized sam-
ples of exposed and unexposed controls.
This is possible using counter-matching.
Example 3. The Beaverlodge Uranium
Miners Cohort. In this study, radon expo-
sure histories were assembled for 10,908
miners ever employed at the Beaverlodge
Mine between 1950 and 1980. After an
initial analysis of the cohort to describe
associations between radon exposure and
lung cancer mortality (9), the extent to
which smoking confounded the observed
relative risks for radon exposure was inves-
tigated in a nested case-control sample
(10). Each of 89 cases was matched to
three controls matched as closely as possi-
ble for birth year, province ofdeath, and
year ofdeath. The final study group con-
sisted of46 cases and 95 controls forwhom
next of kin were found who agreed to be
interviewed regarding the subject's smok-
ing and occupational histories and provid-
ing demographic information. The results
indicate that radon exposure was "nega-
tively confounded" by smoking, i.e., the
adjusted relative risks for radon are higher
than the unadjusted. A counter-matched
sample would have used the radon expo-
sure information to stratify the sample.
Risk-set members would be classified into
strata defined by their radon exposure at
the age of the death of the case. When
exposure is a continuous measure such as
this, subjects should be classified so that
about equal numbers of cases appear in
each stratum. If the distribution of expo-
sure does not change much with age,
classification could be done by dividing at
median exposure of the cases and taking
equal numbers from the two groups.
Otherwise, the method described in
Langholz and Borgan (7) could be used.
Example 4. Effectiveness ofCancer
Screening. Nested case-control studies have
proved extremely useful in providing evi-
dence for the effectiveness ofcancer screen-
ing programs. For example, Verbeek et al.
(11) employed the population register used
to generate breast cancer screening
appointments to define a study cohort. The
outcome of interest was death from breast
cancer and the exposure ofinterest was the
screening history-it was hoped that
screened women would have a lower mor-
tality rate from breast cancer than
unscreened women. For each death, a set of
controls was drawn from the corresponding
risk set and the screening histories ofcases
and controls were compared. Studies such
as this can be carried out using only the
screening program records plus linked
mortality data; and, in principle, the nested
case-control design is unnecessary since
screening histories are available for the
whole cohort. However, an apparent
benefit ofscreening may be attributable to
differences between program compliers and
noncompliers with respect to other aspects
ofbehavior. To exclude such confounding,
a more detailed nested case-control study
could be carried out, in which information
about possible confounders would be
sought. However, simple sampling ofrisk
sets might yield rather few unscreened con-
trols, and a counter-matched design could
be more efficient.
We have investigated the efficiency of
counter-matching for this purpose analyti-
cally. Let Z4 be the exposure known for the
full cohort and 4- be the confounder to be
collected for the sample. Both are assumed
dichotomous. The associations between Z4
and 42 and disease, when they are mutually
adjusted, are given by the relative risks '/1
and 2) and the strength of association
between the exposure and confounder is
measured by the odds ratio
= Pr(Z1 =1,Z2 =I)Pr(Zl =0,Z2 =0)
Pr(Z1 = 1,Z2 =0)Pr(Z1 =0,Z2 = 1)
Table 3 shows the relative efficiencies of
the counter-matched design compared to a
simple nested case-control design for esti-
mating the exposure log relative risk logyrl
after controlling for a confounder, Z2. A
range ofvalues for the effects Vi1 and Vf2
and for the exposure:confounder odds ratio
9 are investigated when both exposure and
confounder are rare and when both are
common. In addition to 1:1 matched sam-
ples, a "balanced" 1:3 counter-matched
sample, i.e., with two exposed and two
unexposed subjects in each case-control set,
is compared to a 1:3 simple nested case-
control sample. As expected, the counter-
matched study has a marked efficiency
advantage, especially in the rare exposure
situation. In this case, the relative efficiency
increases sharply with increasing relative
risk of exposure (ipl). When exposure is
common, this increase is much less pro-
nounced and, in fact, may decrease, reflect-
ing the difference in efficiency behavior of
nested case-control sampling for rare and
common exposures (5). The last two
columns of the table give the relative
efficiencies of the 1:1 counter-matched
sample to the full cohort. In the rare expo-
sure situation, the efficiency is quite high
except when the Z2 is strongly associated
with both disease and exposure. (Note that
in this case it is still much better than sim-
ple nested case-control sampling.) In the
situation where Z2 is associated with nei-
ther disease nor exposure (V/2= 0=1.0),
counter-matching is fully efficient. This
behavior is to be expected, since stong con-
founders are highly relevant to assessing the
Table 3. ARE ofcounter-matched studyforestimating the effect of exposure aftercontrolling fora confounder.
Pr(Z=1)=0.01, Pr(Z2=1)=0.05
1:1 counter-matched 1:3 counter-matched 1:1 counter-matched
(vs simple 1:1) (vs simple 1:3) (vs full cohort)
12 0 '=1 =4 V/1=1 v4 1141=1 wi=4
0.2 0.10 1.97 4.80 1.35 2.33 0.95 0.95
1.00 2.00 4.82 1.35 2.31 0.97 0.97
10.0 1.93 4.36 1.32 2.20 0.99 0.98
1.0 0.10 1.93 4.68 1.33 2.27 0.96 0.96
1.00 2.00 4.85 1.33 2.28 1.00 1.00
10.0 1.56 3.83 1.31 2.15 0.78 0.81
5.0 0.10 1.95 4.49 1.32 2.17 0.99 0.99
1.00 2.00 4.73 1.43 2.41 0.89 0.89
10.0 1.33 3.52 1.64 2.58 0.38 0.42
P(Zj=1)=0.5, P4(Z2=1)=0.5
1:1 counter-matched 1:3 counter-matched 1:1 counter-matched
(vs simple 1:1) (vs simple 1:3) (vs full cohort)
V,2 0 Vf'=1 =4 =1 yi1=4 i =1 =4
0.2 0.10 1.70 1.81 1.25 1.21 0.66 0.84
1.00 2.00 1.93 1.33 1.29 0.78 0.78
10.0 1.70 1.45 1.25 1.22 0.66 0.46
1.0 0.10 1.57 1.48 1.22 1.19 0.79 0.71
1.00 2.00 2.00 1.33 1.27 1.00 1.00
10.0 1.57 1.48 1.22 1.19 0.79 0.71
5.0 0.10 1.70 1.45 1.25 1.22 0.66 0.46
1.00 2.00 1.93 1.33 1.29 0.78 0.78
10.0 1.70 1.81 1.25 1.21 0.66 0.84
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Table 4. ARE of counter-matched study for estimating the effect of exposure after controlling for a confounder.
Pr(Z=1)=0.05, Pr(Z2=1)=0.01
1:1 counter-matched 1:3 counter-matching 1:1 counter-matching
(vs simple 1:1) (vs simple 1:3) (vs full cohort)
w92 0 4i=1 =4 v=1 =4 =1 =4
0.2 0.10 0.26 0.63 0.90 0.93 0.21 0.52
1.00 0.30 0.74 0.91 0.97 0.24 0.58
10.0 0.55 1.23 0.95 1.12 0.46 0.80
1.0 0.10 0.11 0.37 0.70 0.78 0.05 0.19
1.00 0.19 0.62 0.73 0.90 0.09 0.29
10.0 0.67 1.87 0.89 1.42 0.34 0.60
5.0 0.10 0.09 0.28 0.50 0.59 0.02 0.05
1.00 0.29 0.74 0.58 0.84 0.03 0.12
10.0 1.31 3.03 0.97 1.97 0.08 0.35
Pr(Zl=l)=0.5, Pr(Z2=1)=0.5
1:1 counter-matched 1:3 counter-matching 1:1 counter-matching
(vs simple 1:1) (vs simple 1:3) (vs full cohort)
V2 e v=1 v'l=4 v1=l v'l=4 /1=1=4
0.2 0.10 1.08 0.85 1.02 1.01 0.51 0.41
1.00 1.00 0.83 1.00 0.97 0.50 0.36
10.0 1.08 0.93 1.02 0.98 0.51 0.31
1.0 0.10 1.00 0.78 1.00 0.99 0.50 0.32
1.00 1.00 0.78 1.00 0.99 0.50 0.32
10.0 1.00 0.78 1.00 0.99 0.50 0.32
5.0 0.10 1.08 0.93 1.02 1.01 0.51 0.31
1.00 1.00 0.83 1.00 0.99 0.50 0.36
10.0 1.08 0.85 1.02 1.05 0.51 0.41
true association between exposure and dis-
ease, whereas factors that are neither
related to disease nor exposure are irrele-
vant, and there is nothing to be gained by
efficient sampling designs to study such a
factor.
Discussion
In this article we have shown that match-
ing and counter-matching have opposite
roles and both, when properly used, can
lead to gains in efficiency. Matching
should be used for stratified sampling with
respect to a confounder while counter-
matching should be used for stratified sam-
pling with respect to an exposure of
interest or a proxy.
Reversal of these roles is not advanta-
geous. Matching for a variable closely asso-
ciated with exposure is known to lead to
reduced efficiency and is called overmatch-
ing. Likewise, counter-matching with
respect to a confounder should not be con-
sidered. Table 4 shows the relative efficien-
cies for estimating the rate ratio for
exposure, yr, in this situation; counter-
matching may be seen usually to be very
inefficient.
Nested case-control studies are very
useful for assessing the determinants of
variations ofcancer rates within a popula-
tion. Because subjects in the cohort are
identified without regard to disease status,
there is little risk ofthe selection biases that
may occur in a purely retrospective case-
control study. For data generated from
material collected as part of the cohort
study, information bias is less likely
because it is collected prior to the onset of
disease. Substantial cost savings often may
be realized by restricting data extraction
and coding to the nested case-control sam-
ple. Other source data may also be gathered
"retrospectively" on the sampled subjects,
although the danger of information bias
would need to be carefully considered.
Simple nested case-control sampling is
generally quite cost effective relative to the
analysis of the entire cohort. The increase
in efficiency per additional control depends
upon what is being investigated in the sub-
study and the level ofefficiency is deter-
mined by the number ofcontrols per case.
In many important situations, such as
assessing the relationship between disease
and a rare exposure, evaluation of the role
ofconfounding, or variation in relative risk
with a potential effect modifier, many con-
trols may be required to achieve a specified
level ofefficiency. Matching and counter-
matching provide alternative means to this
end by using information collected for the
entire cohort to stratify the sampling in
such a way as to increase the efficiency per
sampled control compared to simple nested
case-control sampling. The cost effective-
ness ofthese strategies will depend on the
and the cost ofcollecting and coding strati-
fying variables.
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